Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Histol Histopathol. 2013 Mar;28(3):345-51. doi: 10.14670/HH-28.345.
Hirschsprung's disease (HD) is one of the most common motility disorders in pediatric age groups and it is very important that it be differentiated from other types of motility disorders, especially intestinal neuronal dysplasia B (IND B). Although many studies regarding the differences between the two disorders by immunohistochemical studies exist, there is as yet no consistent result. The purpose of this research was to study the immunohistochemical findings of enteric nervous system in these two motility disorders in comparison with colectomies without motility disorder.
Full wall thickness specimens of three groups of patients (HD, IND B and non motility disorders) were included in the study to be evaluated by immunohistochemistry (IHC). Markers were specific for neuronal cells and pace maker cells composed of PGP 9.5, c-kit, synaptophysin, S100 and CD56. The number of cells was evaluated in the muscularis properia, and myenteric plexus.
The number of all the IHC markers i.e. PGP9.5, c-kit, synaptophysin, S100 and CD56 was completely different in HD from the two other groups, while IND B was quite similar to control group.
Our finding suggests that there is a marked and significant difference between HD and IND B by IHC markers, which can be used as an additional test for the diagnosis of HD with more accuracy. Further multicenter studies with a greater number of cases would be necessary to find a cut-off point for every IHC marker to differentiate HD and IND B.
先天性巨结肠(HD)是小儿时期最常见的动力障碍之一,将其与其他类型的动力障碍(尤其是肠神经元发育不良 B 型,IND B)区分开来非常重要。尽管有许多关于两种疾病通过免疫组织化学研究的差异的研究,但目前还没有一致的结果。本研究旨在通过免疫组织化学研究,比较这两种动力障碍与无动力障碍的结肠切除术,研究肠神经系统的免疫组织化学发现。
本研究纳入了三组患者(HD、IND B 和非动力障碍)的全壁厚度标本,通过免疫组织化学(IHC)进行评估。标记物是针对神经元细胞和起搏细胞的,由 PGP 9.5、c-kit、突触素、S100 和 CD56 组成。在固有肌层和肌间神经丛中评估细胞数量。
所有免疫组织化学标志物(PGP9.5、c-kit、突触素、S100 和 CD56)在 HD 组与其他两组之间的数量完全不同,而 IND B 与对照组非常相似。
我们的发现表明,HD 和 IND B 之间存在明显而显著的差异,这些差异可以作为诊断 HD 的附加测试,以提高诊断的准确性。需要进行更多的多中心研究,并纳入更多的病例,以找到每个免疫组织化学标志物的截止值,从而区分 HD 和 IND B。